• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物组及其代谢产物在代谢性疾病中的作用。

The role of the gut microbiome and its metabolites in metabolic diseases.

机构信息

Department of Obstetrics and Gynecology, Center for Obesity and Metabolic Disease Research, School of Basic Medical Sciences, Third Hospital, Peking University, Beijing, 100191, China.

Center of Basic Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing, 100191, China.

出版信息

Protein Cell. 2021 May;12(5):360-373. doi: 10.1007/s13238-020-00814-7. Epub 2020 Dec 21.

DOI:10.1007/s13238-020-00814-7
PMID:33346905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8106557/
Abstract

It is well known that an unhealthy lifestyle is a major risk factor for metabolic diseases, while in recent years, accumulating evidence has demonstrated that the gut microbiome and its metabolites also play a crucial role in the onset and development of many metabolic diseases, including obesity, type 2 diabetes, nonalcoholic fatty liver disease, cardiovascular disease and so on. Numerous microorganisms dwell in the gastrointestinal tract, which is a key interface for energy acquisition and can metabolize dietary nutrients into many bioactive substances, thus acting as a link between the gut microbiome and its host. The gut microbiome is shaped by host genetics, immune responses and dietary factors. The metabolic and immune potential of the gut microbiome determines its significance in host health and diseases. Therefore, targeting the gut microbiome and relevant metabolic pathways would be effective therapeutic treatments for many metabolic diseases in the near future. This review will summarize information about the role of the gut microbiome in organism metabolism and the relationship between gut microbiome-derived metabolites and the pathogenesis of many metabolic diseases. Furthermore, recent advances in improving metabolic diseases by regulating the gut microbiome will be discussed.

摘要

众所周知,不健康的生活方式是代谢性疾病的主要危险因素,而近年来,越来越多的证据表明,肠道微生物组及其代谢物在许多代谢性疾病(包括肥胖、2 型糖尿病、非酒精性脂肪肝病、心血管疾病等)的发生和发展中也起着至关重要的作用。大量微生物栖息在胃肠道中,胃肠道是能量获取的关键接口,可以将膳食营养素代谢为许多生物活性物质,从而成为肠道微生物组与其宿主之间的联系。肠道微生物组受宿主遗传、免疫反应和饮食因素的影响。肠道微生物组的代谢和免疫潜力决定了其在宿主健康和疾病中的重要性。因此,针对肠道微生物组及其相关代谢途径的治疗方法可能是未来治疗许多代谢性疾病的有效方法。本综述将总结肠道微生物组在机体代谢中的作用以及肠道微生物组衍生代谢物与许多代谢性疾病发病机制之间的关系。此外,还将讨论通过调节肠道微生物组来改善代谢性疾病的最新进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b64/8106557/5aae052a156b/13238_2020_814_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b64/8106557/5aae052a156b/13238_2020_814_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b64/8106557/5aae052a156b/13238_2020_814_Fig1_HTML.jpg

相似文献

1
The role of the gut microbiome and its metabolites in metabolic diseases.肠道微生物组及其代谢产物在代谢性疾病中的作用。
Protein Cell. 2021 May;12(5):360-373. doi: 10.1007/s13238-020-00814-7. Epub 2020 Dec 21.
2
[The intestinal microbiome and metabolic diseases : From obesity to diabetes and nonalcoholic steatohepatitis].[肠道微生物群与代谢性疾病:从肥胖到糖尿病和非酒精性脂肪性肝炎]
Internist (Berl). 2017 May;58(5):441-448. doi: 10.1007/s00108-017-0229-9.
3
Disruptions in gut microbial-host co-metabolism and the development of metabolic disorders.肠道微生物-宿主共代谢紊乱与代谢性疾病的发生。
Clin Sci (Lond). 2018 Apr 16;132(7):791-811. doi: 10.1042/CS20171328.
4
Microbiome and NAFLD: potential influence of aerobic fitness and lifestyle modification.微生物群与非酒精性脂肪性肝病:有氧运动能力和生活方式改变的潜在影响
Physiol Genomics. 2017 Aug 1;49(8):385-399. doi: 10.1152/physiolgenomics.00012.2017. Epub 2017 Jun 9.
5
Gut Microbiota as a Therapeutic Target for Metabolic Disorders.肠道微生物群作为代谢紊乱的治疗靶点。
Curr Med Chem. 2018;25(9):984-1001. doi: 10.2174/0929867324666171009121702.
6
Gut microbial metabolites in obesity, NAFLD and T2DM.肥胖、非酒精性脂肪性肝病和 T2DM 中的肠道微生物代谢产物。
Nat Rev Endocrinol. 2019 May;15(5):261-273. doi: 10.1038/s41574-019-0156-z.
7
Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications.综述文章:肠道微生物组在非酒精性脂肪性肝病进展中的新作用及其潜在的治疗意义。
Aliment Pharmacol Ther. 2019 Jul;50(2):144-158. doi: 10.1111/apt.15314. Epub 2019 May 31.
8
The Metabolic Role of Gut Microbiota in the Development of Nonalcoholic Fatty Liver Disease and Cardiovascular Disease.肠道微生物群在非酒精性脂肪性肝病和心血管疾病发生发展中的代谢作用
Int J Mol Sci. 2016 Jul 29;17(8):1225. doi: 10.3390/ijms17081225.
9
Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.了解肠道微生物组和微生物代谢产物在肥胖及肥胖相关代谢紊乱中的作用:当前的证据和观点。
Curr Obes Rep. 2019 Sep;8(3):317-332. doi: 10.1007/s13679-019-00352-2.
10
Emerging Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease: From Composition to Function.肠道微生物组在非酒精性脂肪性肝病中的新作用:从组成到功能。
Clin Gastroenterol Hepatol. 2019 Jan;17(2):296-306. doi: 10.1016/j.cgh.2018.08.065. Epub 2018 Sep 7.

引用本文的文献

1
Christensenella tenuis alleviates endotoxemia and metabolic disorders via inhibition of intestinal lipopolysaccharide translocation.纤细克里斯滕森菌通过抑制肠道脂多糖易位减轻内毒素血症和代谢紊乱。
Sci China Life Sci. 2025 Sep 10. doi: 10.1007/s11427-025-3014-6.
2
Artificial intelligence and computational methods in human metabolism research: A comprehensive survey.人类新陈代谢研究中的人工智能与计算方法:全面综述。
J Pharm Anal. 2025 Aug;15(8):101437. doi: 10.1016/j.jpha.2025.101437. Epub 2025 Aug 18.
3
Alterations in gut microbiota and metabolomic profiles in acute stroke: insights into brain-gut axis dysregulation.

本文引用的文献

1
Methionine restriction alleviates high-fat diet-induced obesity: Involvement of diurnal metabolism of lipids and bile acids.限制蛋氨酸摄入可减轻高脂饮食诱导的肥胖:涉及脂质和胆汁酸的昼夜代谢。
Biochim Biophys Acta Mol Basis Dis. 2020 Nov 1;1866(11):165908. doi: 10.1016/j.bbadis.2020.165908. Epub 2020 Jul 31.
2
YRL577 ameliorates markers of non-alcoholic fatty liver and alters expression of genes within the intestinal bile acid pathway.YRL577 可改善非酒精性脂肪肝的标志物,并改变肠道胆汁酸代谢途径相关基因的表达。
Br J Nutr. 2021 Mar 14;125(5):521-529. doi: 10.1017/S0007114520003001. Epub 2020 Jul 28.
3
A metabolic pathway for bile acid dehydroxylation by the gut microbiome.
急性卒中时肠道微生物群和代谢组学特征的改变:对脑-肠轴失调的见解
Front Microbiol. 2025 Aug 22;16:1580231. doi: 10.3389/fmicb.2025.1580231. eCollection 2025.
4
Dynamic male mouse gut microbiota signature linked to improved wound healing of a novel salecan hydrogel dressing.动态雄性小鼠肠道微生物群特征与新型膳食纤维水凝胶敷料伤口愈合改善相关
Front Bioeng Biotechnol. 2025 Aug 21;13:1584976. doi: 10.3389/fbioe.2025.1584976. eCollection 2025.
5
The combination of dietary active dry yeast and improves productive performance, egg quality, and immunity of aged breeder hens.日粮中添加活性干酵母可提高老龄种母鸡的生产性能、蛋品质和免疫力。 (原句表述不太完整,推测可能是“添加活性干酵母”,以上译文基于此推测完善了句子意思)
Anim Nutr. 2025 Jun 6;22:442-458. doi: 10.1016/j.aninu.2025.04.004. eCollection 2025 Sep.
6
Dietary fiber enhances milk yield in plateau dairy cows via activation of the rumen microbiota-mammary gland axis.膳食纤维通过激活瘤胃微生物群-乳腺轴提高高原奶牛的产奶量。
Front Vet Sci. 2025 Aug 12;12:1654799. doi: 10.3389/fvets.2025.1654799. eCollection 2025.
7
EGCG and Taurine Synergistically Ameliorate Lipid Metabolism Disorder by Modulating Gut Microbiota and PPARα/FAS Signaling Pathway.表没食子儿茶素没食子酸酯(EGCG)和牛磺酸通过调节肠道微生物群和PPARα/FAS信号通路协同改善脂质代谢紊乱。
Nutrients. 2025 Aug 9;17(16):2595. doi: 10.3390/nu17162595.
8
Gut microbiota and tuberculosis.肠道微生物群与结核病
Imeta. 2025 Jun 22;4(4):e70054. doi: 10.1002/imt2.70054. eCollection 2025 Aug.
9
Unraveling the gut-immune-kidney axis in kidney stone disease: a two-step Mendelian randomization investigation.解析肾结石疾病中的肠道-免疫-肾脏轴:一项两步孟德尔随机化研究
Urolithiasis. 2025 Aug 20;53(1):160. doi: 10.1007/s00240-025-01830-0.
10
Red yeast rice extract improves lipid metabolism by modulating gut microbiota in high-fat diet mice.红曲米提取物通过调节高脂饮食小鼠的肠道微生物群来改善脂质代谢。
Front Pharmacol. 2025 Aug 1;16:1608582. doi: 10.3389/fphar.2025.1608582. eCollection 2025.
肠道微生物组胆汁酸去羟化的代谢途径。
Nature. 2020 Jun;582(7813):566-570. doi: 10.1038/s41586-020-2396-4. Epub 2020 Jun 17.
4
Inclusion of Limited Amounts of Extruded Legumes Plus Cereal Mixes in Normocaloric or Obesogenic Diets for Rats: Effects on Lipid Profile.在大鼠的正常热量或致肥胖饮食中添加少量挤压豆类与谷物混合物:对血脂谱的影响。
Foods. 2020 Jun 1;9(6):704. doi: 10.3390/foods9060704.
5
Increasing the Hindgut Carbohydrate/Protein Ratio by Cecal Infusion of Corn Starch or Casein Hydrolysate Drives Gut Microbiota-Related Bile Acid Metabolism To Stimulate Colonic Barrier Function.通过盲肠灌注玉米淀粉或酪蛋白水解物提高后肠碳水化合物/蛋白质比例可驱动肠道微生物群相关的胆汁酸代谢,从而刺激结肠屏障功能。
mSystems. 2020 Jun 2;5(3):e00176-20. doi: 10.1128/mSystems.00176-20.
6
Protective Mechanism of Common Buckwheat ( Moench.) against Nonalcoholic Fatty Liver Disease Associated with Dyslipidemia in Mice Fed a High-Fat and High-Cholesterol Diet.普通荞麦(Moench.)对高脂高胆固醇饮食诱导的血脂异常非酒精性脂肪肝的保护机制。
J Agric Food Chem. 2020 Jun 17;68(24):6530-6543. doi: 10.1021/acs.jafc.9b08211. Epub 2020 May 18.
7
Cholesterol homeostasis associated with probiotic supplementation in vivo.体内益生菌补充与胆固醇稳态的关系。
J Appl Microbiol. 2020 Nov;129(5):1374-1388. doi: 10.1111/jam.14678. Epub 2020 Jun 10.
8
Global chemical effects of the microbiome include new bile-acid conjugations.微生物组的全球化学效应包括新的胆汁酸缀合。
Nature. 2020 Mar;579(7797):123-129. doi: 10.1038/s41586-020-2047-9. Epub 2020 Feb 26.
9
Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake.地中海饮食干预超重和肥胖受试者可降低血浆胆固醇,并可独立于能量摄入改变肠道微生物组和代谢组。
Gut. 2020 Jul;69(7):1258-1268. doi: 10.1136/gutjnl-2019-320438. Epub 2020 Feb 19.
10
Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?非酒精性脂肪性肝病:调节肠道微生物群以改善严重程度?
Gastroenterology. 2020 May;158(7):1881-1898. doi: 10.1053/j.gastro.2020.01.049. Epub 2020 Feb 8.